MLH1 and neoplasm: To further understand the tumour DNA methylation differences between those with sporadic (acquired) versus constitutional MLH1 promoter hypermethylation, we compared the genome-wide DNA methylation profiles of sporadic MLH1 methylated CRCs (n = 9) with those from MLH1 epimutation CRCs (n = 6) to identify DMRs.